Tuesday, June 27, 2023

'Stunning' Emails Show What Biden Administration Officials Knew About COVID Vaccines Very Early On

Newly released emails obtained through a Freedom of Information Act request show that public health officials knew about “breakthrough cases" of COVID-19 in vaccinated individuals early on, but continued pushing vaccine mandates anyway.

Centers for Disease Control and Prevention Director Rochelle Walensky discussed in a January 2021 email how she had spoken to then-NIH Director Francis Collins about the issue.

“Dear all, I had a call with Francis Collins this morning and one of the issues we discussed was that of vaccine breakthroughs. This is clearly and [sic] important area of study and was specifically called out this week here,” she said, adding a link to a paper titled, “SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.” She goes to say she discussed this with someone “a few weeks ago” and that Dr. Anthony Fauci was also aware.

In media hits months later, however, Walensky was saying that vaccinated individuals “don’t get sick” and “do not carry the virus.”

"Our data from the CDC today suggests that vaccinated people do not carry the virus, don't get sick, and that it's not just in the clinical trials, but it's also in real-world data,” she said on MSNBC in March of 2021.

She then defended those comments in a congressional hearing, arguing it was true when she said it, though it “did change over time.”

In May of 2021, Fauci made similar claims, telling Americans that vaccinated individuals "become a dead end to the virus."

"Even though there are breakthrough infections with vaccinated people, almost always the people are asymptomatic and the level of virus is so low it makes it extremely unlikely — not impossible but very, very low likelihood — that they’re going to transmit it,” Fauci told CBS's "Face the Nation."

“When you get vaccinated, you not only protect your own health and that of the family but also you contribute to the community health by preventing the spread of the virus throughout the community,” he added. “In other words, you become a dead end to the virus. And when there are a lot of dead ends around, the virus is not going to go anywhere. And that’s when you get a point that you have a markedly diminished rate of infection in the community.”

Sharing the email, Stanford School of Medicine professor Jay Bhattacharya called the revelation "stunning."


Australia Removes Moderna Vaccine for Children Under 5

Health authorities in Australia have quietly removed Moderna’s paediatric COVID-19 vaccine for children five years and under, with both options offered by the company now no longer available in the country.

This comes after the Australian Technical Advisory Group on Immunisation (ATAGI) announced it would no longer recommend COVID-19 vaccines for individuals who are under five unless they have one of seven specific high-risk medical conditions that could place them in heightened-risk categories for severe COVID-19.

The seven conditions include severe primary or secondary immunodeficiency, including those undergoing treatment for cancer or those on immunosuppressive treatments; bone marrow or stem cell transplant or chimeric antigen T-cell (CAR-T) therapy; complex congenital cardiac disease, structural airway anomalies or chronic lung disease, type 1 diabetes mellitus, chronic neurological or neuromuscular conditions or a disability with significant or complex health needs.

“ATAGI does not currently recommend vaccination for children aged 6 months to <5 years who are not in the above risk categories for severe COVID-19. These children have a very low likelihood of severe illness from COVID-19,” the advisory body said.

The Epoch Times has reached out to Moderna for comment on the decision.

Moderna Vaccine Only Gave Modest Protection: ATAGI
In justifying its change of advice, the health authority said that there was a very low risk of severe COVID-19 in healthy children aged six months to less than five years.

“This age group is one of the least likely age groups to require hospitalisation due to COVID-19. Among the small number who are hospitalised or who die due to COVID-19, underlying medical conditions or immunocompromise are frequently present,” ATAGI said.

They also noted that the age cohort had a relatively low rate of paediatric inflammatory multisystem syndrome (PIMS-TS) following COVID-19 compared to other older children, and this further declined with the Omicron variant compared to ancestral SARS CoV-2 strains.

Further, the health advisory group noted that a clinical trial of 5,500 children aged six months up to five years demonstrated that the Moderna COVID-19 vaccine provided only modest protection against infection, while safety data reported patterns of vaccine-related adverse events.

“Up to one in four children in this age group had a fever following vaccination with Moderna vaccine, with higher rates seen in those with a history of previous COVID-19,” they said.

“As fever in this age group can sometimes result in medical review and/or investigations and occasionally trigger a febrile convulsion, the side effect profile for this vaccination needs to be considered in the risk-benefit discussion.”

Additionally, the health authorities also changed their advice on COVID-19 booster shots for those 18 and under, with the body now recommending that children and adolescents aged under 18 years who do not have any risk factors for severe COVID-19, should not receive a booster shot.

Omission of Children’s COVID-19 Vaccine Deaths In Australia Raises Concerns

The changing advice follows concerns in March that Australia’s drug regulator was too slow to update the country’s Database of Adverse Event Notifications (DAEN) despite several deaths being attributed to the vaccine, including two children, aged 7 and 9.

The information came to light following a Freedom of Information request by an Australian doctor that found the delayed response from the Therapeutic Goods Administration (TGA).

Senator Gerard Rennick said he would push for independent oversight of the TGA.

“A third independent medical party should examine the evidence as the TGA has a conflict of interest because they approved the vaccines and would therefore be held responsible for the deaths of these children due to poor regulatory oversight,” Rennick told The Epoch Times.

The senator also said he was concerned that the TGA was soft-pedalling the risks with the COVID-19 vaccines, especially around myocarditis and cardiac arrests.

“They are definitely downplaying the risks. They do not have enough information to rule it out given the known link between the vaccines and myocarditis and myocarditis and cardiac arrests,” Rennick said.

The TGA states that they “rigorously assess any COVID-19 vaccine for safety, quality and effectiveness before it can be supplied in Australia.”

As of June 19, the DAEN states that since the beginning of the vaccination rollout in Australia, there have been 138,645 adverse events reported to the federal government. Of those, 135,126 are believed to be directly related to the vaccines, while 991 are reportedly vaccine-related deaths.

Further, in the age cohort of six months to 17, there have been 5,817 adverse events recorded, with 5,689 attributed solely to COVID-19 vaccines. Nine children and adolescents have also reportedly died as a result of an adverse vaccine reaction.


Large 1.3M Observational Study on Vaccine & Previous Infection-Based Effectiveness Against Omicron

How effective are the COVID-19 vaccines in children? This is a study question pursued by a biomedical research team led by physicians and scientists at University of North Carolina Gillings School of Public Health in an observational cohort study based on electronic health record-based vaccination records involving outcomes associated with Pfizer-BioNTech (BNT162b2) and Moderna (mRNA-1273) mRNA-based COVID-19 vaccines.

Data for this observational type of study originate from the North Carolina COVID-19 Surveillance System and the COVID-19 Vaccine Management System for 1,368,721 North Carolina residents aged 11 years or younger from Oct 29, 2021 (Oct 29, 2021 for children aged 5–11 years and June 17, 2022 for children aged 0–4 years), to Jan 6, 2023. Cox regression statistics were utilized to arrive at time-varying effects of both primary and booster vaccination and previous infection on the risks of Omicron infection, hospital admission and death.

Oddly, the study team didn’t collect side effect data. The authors find the mRNA vaccines effective, but their protective effects wane. The study team touts what is highly robust protection associated with previous infection (natural immunity) which against some parameters wanes slower than vaccination.

This study characterized the long-term effects of vaccination and previous infection to Omicron infection and severe outcomes in children aged 5-11 years. They compared the effectiveness of monovalent and bivalent boosters in the cohort. Also, the investigated estimated the time-varying effects of vaccination and previous infection on omicron infection, and severe outcomes in children aged 0-4 years. The study records covered all lineages of the Omicron variant.


What about primary vaccination vs monovalent booster dose? The study team points out in The Lancet that the effectiveness of a monovalent booster dose after month one equaled 24.4% (14.4-33.2) and that of a bivalent booster dose equaled 76.7% (45.7-90.0%).

What about previous infection? That is, children that were infected with SARS-CoV-2 (Omicron variant), and the protective effect against Omicron reinfection. The data reveals preexisting infection is quite effective at 79.9% (78.8-80.9%) after month three, and 53.9% (52.3%-55.5%) by month 6.

When looking at the youngest cohort—age 0-4 years—the University of North Carolina team found that effectiveness of primary vaccination against infection, when compared to unvaccinated status, equaled 63.8% (57.0-69.5%) by month 2 after the jab, and 58.1% (48.3-66.1%) at month 5 after the first dose.

Previous infection for this cohort, which was frequent and represented low risk overall, exceeded vaccination at 77.3% (75.9-78.6) at month 3 and 64.7% (63.3-66.1) at month 6.

Across both age groups, both vaccination and previous infection were reported as better effectiveness against severe illness as measured by hospital admission or death, as a composite endpoint than against infection.


Vaccination was effective in helping to prevent Omicron infection as well as more severe infection, but like all other studies reveal with the mRNA vaccines, that protection wanes over time. The bivalent boosters were more effective as compared to the monovalent boosters. Importantly, the authors denote, “Immunity acquired via Omicron infection was very high and waned gradually over time.”


Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com (TONGUE-TIED)

https://immigwatch.blogspot.com (IMMIGRATION WATCH)

https://awesternheart.blogspot.com (THE PSYCHOLOGIST)

http://jonjayray.com/blogall.html More blogs


No comments: